SCHEMBL27484906

SCHEMBL27484906

Nc1c(Cl)ccc(C(=O)Nc2ccc(Cl)cc2)c1Cc1ccncc1

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ JAK2 O60674 4/20 0.52
▸ TYK2 P29597 4/20 0.52
▸ JAK1 P23458 2/20 0.52
▸ KDR P35968 6/20 0.51
▸ MAPK1 P28482 1/20 0.50
▸ FLT1 P17948 1/20 0.48
▸ NAMPT P43490 2/20 0.48
▸ LMNA P02545 1/20 0.47
▸ KMT2A Q03164 3/20 0.47
▸ NT5E P21589 1/20 0.47
▸ KDM4E B2RXH2 1/20 0.46
▸ NR3C1 P04150 1/20 0.46
▸ MEN1 O00255 2/20 0.46
▸ ALDH1A1 P00352 1/20 0.46
▸ HPGD P15428 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ KCNMA1 Q12791 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27486256 0.83 KDR (0.57) JAK2TYK2JAK1KDRMAPK1
SCHEMBL27485942 0.82 MAPT (0.49) JAK2TYK2JAK1KDRMAPK1
SCHEMBL27465576 0.81 JAK2 (0.52) JAK2TYK2JAK1KDRMAPK1
SCHEMBL27466160 0.81 JAK1 (0.53) JAK2TYK2JAK1KDRMAPK1
SCHEMBL27486252 0.78 KDR (0.48) JAK2TYK2JAK1KDRMAPK1
SCHEMBL27485591 0.75 TYK2 (0.49) TYK2JAK1KDRMAPK1FLT1
SCHEMBL27467102 0.72 SMN1; SMN2 (0.54) KDRMAPK1LMNAKMT2AKDM4E
SCHEMBL27548625 0.72 KDR (0.59) JAK1KDRFLT1NAMPTKMT2A
SCHEMBL27486254 0.72 SMN1; SMN2 (0.53) JAK2TYK2JAK1KDRNAMPT
SCHEMBL27609433 0.71 ALDH1A1 (0.52) JAK2JAK1KDRFLT1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1152014-C N-aryl (thio) anthranilic acid amide derivatives, their prepn. and their use as VEGF receptor tyrosine kinase inhibitors ��˹��ŵ�� 2004-06-02 — — CN claimed
CN-1331680-A N-aryl (thio) anthranilic acid amide derivatives, their prepn. and their use as VEGF receptor tyrosine kinase inhibitors NOVARTIS AG (CH) 2002-01-16 — — CN claimed
CN-1152014-C N-aryl (thio) anthranilic acid amide derivatives, their prepn. and their use as VEGF receptor tyrosine kinase inhibitors ��˹��ŵ�� 2004-06-02 — — CN disclosed
CN-1331680-A N-aryl (thio) anthranilic acid amide derivatives, their prepn. and their use as VEGF receptor tyrosine kinase inhibitors NOVARTIS AG (CH) 2002-01-16 — — CN disclosed
Send feedback